ESR1 and triple-negative breast carcinoma: It is a highly diverse cancer, encompassing several distinct subtypes that are categorized into four groups based on hormone receptors, which include estrogen receptor-positive (ER +), progesterone receptor-positive (PR +), human epidermal growth factor receptor 2-positive (HER2 +), and triple-negative breast cancer (TNBC) [1].